Deoxyepinephrine is a dopamine and epinephrine derivative. It is present as a minor alkaloid of peyote, and a breakdown product of ibopamine. It has also been used to treat congestive heart failure.

'Mark Parker is Nike, Inc.'s third CEO, after William Perez resigned in January 2006 citing differences with his predecessor as CEO, Phil Knight.

Parker was born in Poughkeepsie, New York and earned his bachelor's degree in political science at Penn State University in 1977. He ran on the Penn State track team. He joined Nike in 1979 as a footwear designer based in its R&D facility in Exeter, New Hampshire.

Parker has held a variety of positions during his tenure at Nike. He became Division Vice President in charge of development in 1987, Corporate Vice President in 1989, General Manager in 1993, and Vice President of Global Footwear in 1998. Prior to becoming CEO, he served as co-president (with Charlie Denson) of the Nike brand beginning March 2001. Parker's salary for 2008 was $7.6 million. He still participates in shoe design.

Parker has committed to ensuring that Nike remain environmentally conscious. After 10 years of work, Parker and his team launched the first "Green Shoe" that adheres to the principles of sustainability.